Skip to content

Improving Breast Health Knowledge Among Women Using a Gamified Metaverse-Based Platform

Improving Breast Health Knowledge Among Women Using a Gamified Metaverse-Based Platform: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06930898
Enrollment
72
Registered
2025-04-16
Start date
2024-12-01
Completion date
2025-03-24
Last updated
2025-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Neoplasms, Health Education

Keywords

Gamification, Health Education, Breast Cancer Awareness, Metaverse, Women's Health, Digital Health Literacy

Brief summary

This randomized controlled trial aimed to evaluate the effectiveness of Mammoverse, a gamified metaverse-based educational platform, in improving breast health knowledge among women in China. Participants were randomly assigned to either a gamified or non-gamified version of the platform. Both groups received identical educational content, but only the gamified group experienced interactive game elements such as avatars, progress feedback, and rewards. Knowledge was assessed at baseline, immediately post-intervention, and at 4-week follow-up. The study found that the gamified platform significantly improved knowledge retention and participant engagement compared to the non-gamified version. This ClinicalTrials.gov registration reflects only the randomized controlled trial (RCT) portion of a broader mixed-methods study that was approved by the University of Malaya Research Ethics Committee (Ref: UM.TNC2/UMREC\_3967). The full study protocol includes three methodological approaches, and this registration pertains specifically to the RCT component involving the Mammoverse platform. Other study components are not included in this registration.

Detailed description

Mammoverse is a 3D metaverse environment designed to promote breast health knowledge through immersive and interactive learning. The gamified version included user avatars, badges, tasks, and personalized feedback to increase motivation and engagement. The study recruited 72 women aged 18 and above, and used a pre-post-follow-up design. Outcome measures were based on an adapted 18-item Breast Health Literacy Questionnaire. The trial was conducted entirely online, with ethics approval from the University of Malaya Research Ethics Committee.

Interventions

BEHAVIORALGamified Mammoverse Platform

A gamified, metaverse-based platform delivering breast health education through story-based tasks, interactive challenges, points, rewards, badges, and virtual incentives.

BEHAVIORALStandard Mammoverse Platform

A non-gamified version of the Mammoverse platform that provides the same breast health educational content.

Sponsors

University of Malaya
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

Participants were randomly assigned in a 1:1 ratio to one of two parallel groups: a gamified version of the Mammoverse metaverse-based platform or a non-gamified version containing the same educational content.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Female participants aged 18 years and above * Able to read and understand Chinese * Access to a digital device and stable internet connection * Willing to provide informed consent

Exclusion criteria

* Cognitive impairment or mental health condition that affects participation * Inability to complete the full intervention and follow-up sessions * Incomplete baseline assessment

Design outcomes

Primary

MeasureTime frameDescription
Change in Breast Health Knowledge Score from Baseline to 4 Weeks Post-InterventionBaseline and 4 weeks post-interventionAssessed using an 18-item adapted Breast Health Literacy Questionnaire. Scores range from 0 to 18, with higher scores indicating greater knowledge. Main comparison is between baseline and 4-week follow-up.

Secondary

MeasureTime frameDescription
Change in Breast Health Knowledge Score from Baseline to Immediately Post-InterventionBaseline and immediately post-interventionSame questionnaire used to assess immediate knowledge gain after the intervention.

Other

MeasureTime frameDescription
Knowledge Retention from Immediately Post-Intervention to 4 Weeks PostImmediately post-intervention and 4 weeks post-interventionChange in knowledge scores to evaluate retention over 4 weeks.

Countries

China, Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026